RATIONALE: Heparin or enoxaparin may be effective in preventing the formation of blood clots
in patients with cancer who are undergoing surgery to remove the tumor.
PURPOSE: Randomized clinical trial to compare the effectiveness of heparin with that of
enoxaparin in patients who have cancer.